Literature DB >> 20444541

miR-195, miR-455-3p and miR-10a( *) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells.

Kenta Ujifuku1, Norisato Mitsutake, Shu Takakura, Michiko Matsuse, Vladimir Saenko, Keiji Suzuki, Kentaro Hayashi, Takayuki Matsuo, Kensaku Kamada, Izumi Nagata, Shunichi Yamashita.   

Abstract

To identify microRNAs (miRNAs) specifically involved in the acquisition of temozolomide (TMZ) resistance in glioblastoma multiforme (GBM), we first established a resistant variant, U251R cells from TMZ-sensitive GBM cell line, U251MG. We then performed a comprehensive analysis of miRNA expressions in U251R and parental cells using miRNA microarrays. miR-195, miR-455-3p and miR-10a( *) were the three most up-regulated miRNAs in the resistant cells. To investigate the functional role of these miRNAs in TMZ resistance, U251R cells were transfected with miRNA inhibitors consisting of DNA/LNA hybrid oligonucleotides. Suppression of miR-455-3p or miR-10a( *) had no effect on cell growth, but showed modest cell killing effect in the presence of TMZ. On the other hand, knockdown of miR-195 alone displayed moderate cell killing effect, and combination with TMZ strongly enhanced the effect. In addition, using in silico analysis combined with cDNA microarray experiment, we present possible mRNA targets of these miRNAs. In conclusion, our findings suggest that those miRNAs may play a role in acquired TMZ resistance and could be a novel target for recurrent GBM treatment. 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20444541     DOI: 10.1016/j.canlet.2010.04.013

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  101 in total

1.  miR-195 potentiates the efficacy of microtubule-targeting agents in non-small cell lung cancer.

Authors:  Xiaojie Yu; Yiqiang Zhang; Xiuye Ma; Alexander Pertsemlidis
Journal:  Cancer Lett       Date:  2018-04-13       Impact factor: 8.679

Review 2.  Glioblastoma: exosome and microRNA as novel diagnosis biomarkers.

Authors:  L Saadatpour; E Fadaee; S Fadaei; R Nassiri Mansour; M Mohammadi; S M Mousavi; M Goodarzi; J Verdi; H Mirzaei
Journal:  Cancer Gene Ther       Date:  2016-11-11       Impact factor: 5.987

3.  MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT.

Authors:  Er Nie; Xin Jin; Weining Wu; Tianfu Yu; Xu Zhou; Zhumei Shi; Junxia Zhang; Ning Liu; Yongping You
Journal:  J Neurooncol       Date:  2017-04-19       Impact factor: 4.130

Review 4.  MicroRNAs in brain tumors : a new diagnostic and therapeutic perspective?

Authors:  Richard Hummel; Jessica Maurer; Joerg Haier
Journal:  Mol Neurobiol       Date:  2011-07-08       Impact factor: 5.590

5.  A promising light for an impossible disease: miRNAs in malignant gliomas.

Authors:  Yin Yee Sharon Low; Wai Hoe Ng
Journal:  CNS Oncol       Date:  2013-03

Review 6.  Liquid biopsy in central nervous system tumors: the potential roles of circulating miRNA and exosomes.

Authors:  Yirizhati Aili; Nuersimanguli Maimaitiming; Yusufu Mahemuti; Hu Qin; Yongxin Wang; Zengliang Wang
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

7.  MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells.

Authors:  Jing Han; Qianxue Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

8.  Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens.

Authors:  Aysegül Ilhan-Mutlu; Adelheid Wöhrer; Anna Sophie Berghoff; Georg Widhalm; Christine Marosi; Ludwig Wagner; Matthias Preusser
Journal:  J Neurooncol       Date:  2013-02-19       Impact factor: 4.130

9.  miR-181 subunits enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeleton remodeling in glioblastoma cells.

Authors:  Xiaoling She; Zhibin Yu; Yulong Cui; Qianqian Lei; Zeyou Wang; Gang Xu; Zhaohui Luo; Guiyuan Li; Minghua Wu
Journal:  Med Oncol       Date:  2014-02-27       Impact factor: 3.064

10.  MicroRNAs 125a and 455 repress lipoprotein-supported steroidogenesis by targeting scavenger receptor class B type I in steroidogenic cells.

Authors:  Zhigang Hu; Wen-Jun Shen; Fredric B Kraemer; Salman Azhar
Journal:  Mol Cell Biol       Date:  2012-10-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.